Media Mentions
Description:
In an article for the Washington Post, government and regulatory partner Libby Baney discussed how ongoing trade concerns are impacting the pharmaceutical market.
The article noted that prescription drug costs have soared and shipments have been delayed due to uncertain international trade policies. Baney added that because of the uncertainty, an influx of bad actors selling untested and unregulated drugs has only increased the problem for the for the estimated 2 million Americans who buy medicine abroad.
“[That can carry] serious, and sometimes life-threatening, risks,” Baney said.